FDA requires labeling updates for prescription stimulants to improve safe use

被引：0

|

作者：

不详

机构：

来源：

NURSE PRACTITIONER | 2023年 / 48卷 / 08期

关键词：

D O I：

暂无

中图分类号：

R47 [护理学];

学科分类号：

1011 ;

摘要：

引用

收藏

页码：48 / 48

页数：1

相关论文

共 50 条

[1] FDA updates Boxed Warning and prescribing information for stimulants
Reactions Weekly, 2023, 1957 (1) : 2 - 2
[2] FDA requires new strategy to ensure safe use of LABAs
Reactions Weekly, 2010, 1290 (1) : 3 - 3
[3] FDA requires antibiotic resistance labeling
不详
AMERICAN JOURNAL OF NURSING, 2003, 103 (05) : EE5 - EE5
[4] FDA boosts efforts to improve safe use of pharmaceuticals
Wechsler, J
FORMULARY, 2001, 36 (04) : 308 - 309
[5] Predictors of Nonmedical Use of Prescription Stimulants
Lookatch, Samantha J.
Dunne, Eugene M.
Katz, Elizabeth C.
JOURNAL OF PSYCHOACTIVE DRUGS, 2012, 44 (01) : 86 - 91
[6] FDA requires updates to prescribing information for all opioid analgesics
Reactions Weekly, 2023, 1953 (1) : 1 - 1
[7] Nonmedical use of prescription stimulants among students
Arria, AM
Wish, ED
PSYCHIATRIC ANNALS, 2005, 35 (03) : 228 - 235
[8] Nonmedical use of prescription stimulants among students
Arria, Amelia M.
Wish, Eric D.
PEDIATRIC ANNALS, 2006, 35 (08): : 565 - 571
[9] Nonmedical use of prescription stimulants in the United States
Kroutil, Larry A.
Van Brunt, David L.
Herman-Stahl, Mindy A.
Heller, David C.
Bray, Robert M.
Penne, Michael A.
DRUG AND ALCOHOL DEPENDENCE, 2006, 84 (02) : 135 - 143
[10] Prescription Stimulants in Individuals with and without ADHD - Do They Improve Cognition?
Lakhan, Shaheen
NEUROLOGY, 2013, 80

← 1 2 3 4 5 →